HIV drug resistance early warning indicators in Ethiopia: Variability at regional and health facility levels and trend over time

Int J Infect Dis. 2020 Jun:95:90-97. doi: 10.1016/j.ijid.2020.02.031. Epub 2020 Feb 20.

Abstract

Objective: The aim of this study was to assess status of early warning indicators (EWIs) for HIV drug resistance in Ethiopia.

Methods: A retrospective cohort study was conducted among 90 health facilities (HFs) in 2015. Data were abstracted for 'on time pill pickup' (EWI-I), 'Retention in care' (EWI-II), 'drug supply continuity'(EWI-III) and 'dispensing practices' (EWI-IV). Data analysis was conducted using WHO Excel tool and SPSS V20.

Results: EWI-IV was excellent across all of the six rounds of EWI surveys conducted between 2008 and 2015. There were improvements in EWI-II over time from 55.6% to 81%. However, EWI-I and EWI-III declined from 86.7% to 31% and 100% to 41%, respectively. During 2015, half of the HFs in Gambella, Amhara and Southern Nation, Nationalities and people regional (SNNPR) states achieved excellent performance for EWI-I. Similarly, all HFs in Afar, Amhara, Dire Dawa, Harari and Tigray regions achieved excellent performance for EWI-II. There were also differences by level of HFs for EWI-III; 62% of hospitals and 28% of health centers were out of stock of one or more ARV drugs by 2015.

Conclusion: Excellent performance of EWI-IV and improvement of EWI-II over time shall be maintained. The program shall further work to ensure medication adherence and supply continuity.

Keywords: Antiretroviral therapy; Early warning indicators; Ethiopia; HIV drug resistance; HIV/AIDS.

MeSH terms

  • Adult
  • Anti-HIV Agents / therapeutic use*
  • Child
  • Drug Resistance, Viral
  • Ethiopia
  • HIV Infections / drug therapy
  • Health Facilities
  • Humans
  • Medication Adherence
  • Retrospective Studies

Substances

  • Anti-HIV Agents